Pre-Emptive Endovascular Repair for Uncomplicated Type B Dissection - Is This an Option?

Area of Science:

• Cardiovascular Surgery
• Vascular Medicine
• Medical Imaging

Background:

• Type B aortic dissection (TBAD) predominantly affects older men, often linked to hypertension.
• Best Medical Treatment (BMT) is the standard for uncomplicated acute TBAD, focusing on hemodynamic control.
• Thoracic Endovascular Aortic Repair (TEVAR) is increasingly considered for complicated TBAD, aiming to seal entry tears and remodel the aorta.

Purpose of the Study:

• To evaluate the efficacy and optimal timing of TEVAR versus BMT for Type B aortic dissection.
• To analyze the impact of TEVAR on aortic remodeling and long-term outcomes.
• To determine the influence of disease stage (acute, subacute, chronic) on intervention strategies.

Main Methods:

• Review of clinical trials comparing TEVAR and BMT for acute aortic dissection.
• Analysis of data on aortic remodeling, false lumen pressure, and mortality rates.
• Assessment of complication rates related to TEVAR timing in different disease phases.

Main Results:

• TEVAR demonstrates significant advantages in promoting aortic remodeling and reducing long-term aorta-related mortality compared to BMT.
• No significant difference in immediate mortality was observed between TEVAR and BMT in major trials.
• Early TEVAR in the acute phase is associated with higher complication rates due to intimal fragility.

Conclusions:

• TEVAR is a valuable treatment option for Type B aortic dissection, particularly for promoting aortic remodeling and improving long-term survival.
• The subacute phase emerges as an optimal window for TEVAR, offering a balance between beneficial remodeling and minimized procedural risks.
• Careful consideration of disease stage and intimal integrity is crucial for successful TEVAR implementation in TBAD management.